The company adheres to the development strategy of scientific and technological innovation, has the following R&D team leader: Professor Honghao Zhou, Chief Scientific Adviser, academician of Chinese Academy of Engineering(CAE), a pioneer of Chinese pharmacogenetics and pharmacogenomics and an advocate of personalized medicine ; Dr. Pengfei Zhou , Scientific Consultant, founding shareholder, vice chairman and overseas returned scientist; Professor Kan Liu , CTC Technical Consultant, Dean of Electronic and Electrical Engineering School of Wuhan Textile University.

The company has built a high-level scientific research team with professional background in vitro diagnosis industry, the core team consists of over 60 persons, in which Master and PhD account for 90%, many people have working experience in overseas or famous companies in the industry.